Skip to main content

Advertisement

Table 1 Clinical characteristics of the study population and comparative effectiveness of FPT in TN

From: New high intensity fibreoptic phototherapy devices in healthy newborns: a single pad wrapped around the neonate body in comparison with a double pad device

  TN group 1 (57) TN group 2 (43) P
Gestational age (wks) 38.6 ± 1.2 38.7 ± 1.2 0.68
Birthweight (g) 3288 ± 350 3277 ± 443 0.89
Gender (male) 31 (54.4) 25 (58,1) 0.71
AB0 mismatch 17 (29.8) 18 (41.9) 0.21
Rh mismatch 3 (5.3) 2 (4.6) 0.89
Cesarean section 7 (12.3) 4 (9.3) 0.64
Apgar score at 5’ 9.7 ± 0.6 9.8 ± 0.4 0.51
SGA 0 0  
Age at FPT start (h) 63 ± 22 64 ± 21 0.89
TSB at FPT start (mg/dl) 15.4 ± 2.1 15.9 ± 1.8 0.18
TSB at FPT stop (mg/dl) 11.0 ± 1.1 11.1 ± 1.3 0.59
FPT duration (h) 47.6 ± 18.8 42.7 ± 16.8 0.18
TSB reduction at stop of FPT (%) 27.6 ± 10.4 29.0 ± 10.0 0.51
TSB hourly reduction in PT (mg/dl/h) 0.11 ± 0.06 0.14 ± 0.15 0.17
TSB maximum rebound (%) 11.1 ± 26.6 13.0 ± 19.0 0.69
Check numbers after discharge 1.9 ± 1.4 1.6 ± 1.2 0.24
Birthweight variation (%) 3.6 ± 4.2 3.8 ± 3.2 0.79
Weight variation during phototherapy (%) −1.9 ± 5.2 −2.3 ± 2.2 0.60
TSB reduction after 24 h of FPT (%) 16.0 ± 9.0 18.0 ± 9.0 0.27
  1. Data are expressed as mean ± SD or n. (%)